Michalis Papadakis ^UDM

Michalis Papadakis, CEO and Co-Founder of Brainomix, specializes in AI-powered imaging biomarkers for precision medicine. His leadership has steered Brainomix in developing state-of-the-art AI solutions and software that aid physicians globally in making critical medical decisions, especially in cardiovascular and neurological diseases. Since its inception from the University of Oxford, Brainomix has become a leading name in medical AI innovation, enhancing treatment decisions across the world.